エピソード

  • May 2026 CHEST Journal Editor Highlights
    2026/05/01

    CHEST May 2026, Volume 169, Issue 5

    CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST May 2026 issue, including an analysis of interactive pathways of key prognostic factors in severe asthma, an investigation of the long-term safety and efficacy of proximal hypoglossal nerve stimulation in OSA, and more. 

    Moderator:    Peter Mazzone, MD, MPH, FCCP

    続きを読む 一部表示
    19 分
  • Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases
    2026/05/01

    Valerie Dehondt, PharmD, and Lies Lahousse, PharmD, PhD, join CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the association between long-term proton pump inhibitor use and exacerbation risk in patients with chronic obstructive airway diseases.  

    DOI: 10.1016/j.chest.2026.01.002

    Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

    続きを読む 一部表示
    13 分
  • Pseudomonas aeruginosa in Patients With Nosocomial Respiratory Infections: A Secondary Analysis of the European Network for ICU-Related Respiratory Infections
    2026/05/01

    Luis F. Reyes, MD, PhD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the prevalence of Pseudomonas aeruginosa among patients with nosocomial respiratory infections in the ICU.

    DOI: 10.1016/j.chest.2025.12.033

    Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

    続きを読む 一部表示
    26 分
  • April 2026 CHEST Journal Editor Highlights
    2026/04/01

    CHEST April 2026, Volume 169, Issue 4

    CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST April 2026 issue, including an exploration of inspiratory effort and dynamic transpulmonary driving pressure in extremely preterm infants undergoing noninvasive ventilation, an investigation of comparative outcomes and side effects of immunosuppressants and tumor necrosis factor inhibitors in sarcoidosis, and more.

    Moderator:    Peter Mazzone, MD, MPH, FCCP

    続きを読む 一部表示
    20 分
  • Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System
    2026/04/01

    Eduardo Solbes, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the variation in full MIST2 regimen dosing of intrapleural enzyme therapy across 21 hospitals in adults hospitalized with complicated parapneumonic effusion of empyema. 

    DOI: 10.1016/j.chest.2025.11.042

    Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

    続きを読む 一部表示
    20 分
  • March 2026 CHEST Journal Editor Highlights
    2026/03/02

    CHEST March 2026, Volume 169, Issue 3     

    CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2026 issue, including an investigation into a specialist dietary intervention in patients with fibrotic interstitial lung disease experiencing weight loss, an examination of the impact of dual cannabis and tobacco smoking in young patients with lung cancer, and more. 

    Moderator:    Peter Mazzone, MD, MPH, FCCP

    続きを読む 一部表示
    18 分
  • Adjunctive Corticosteroid Use and Clinical Outcomes in Non-HIV Pneumocystis jirovecii Pneumonia
    2026/03/02

    Aaron M. Pulsipher, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the dose-response relationship between adjunctive corticosteroids and outcomes in adult patients with non-HIV Pneumocystis jirovecii pneumonia.

    DOI: 10.1016/j.chest.2025.10.036

    Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

    続きを読む 一部表示
    不明
  • CHEST Critical Care: The Impact of Mechanical Power Normalized to Predicted Body Weight on Outcomes in Pediatric ARDS
    2026/02/16

    Authors Herng Lee Tan, MSc, and Judith Ju Ming Wong, MBBCh, BAO, and editorialist Vicent Modesto i Alapont, MD, PhD, join CHEST® Critical Care Podcast Moderator Dan Fein, MD, to discuss their research into the impact of mechanical power normalized to predicted body weight on outcomes in pediatric ARDS.

    This episode is part of a new series exploring articles published in our open access journal CHEST Critical Care.

    DOI: 10.1016/j.chstcc.2025.100162

    Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

    続きを読む 一部表示
    35 分